Conn's: Court Order Forces Prevagen to Scrub Memory-Improvement Claims

MADISON, CONN., Dec. 12, 2024 (GLOBE NEWSWIRE) -- In a win for consumers, a court has ordered Quincy Bioscience to stop advertising Prevagen using memory-improvement claims. This follows a near-decade-long campaign by the ad watchdog truthinadvertising.org (TINA.org) to bring the jellyfish-based brain supplement company's deceptive marketing to a halt.Sold at major retail stores such as CVS and Walgreens for $40 to $90 per bottle for a month's supply, Prevagen has been promoted widely on national broadcast and cable networks including CNN, Fox News, and NBC since 2013 as "clinically shown" to improve memory loss. However, TINA.org conducted an investigation into Prevagen's marketing in 2015, finding that the company lacked reliable scientific evidence to back up its claims. The ad watchdog subsequently filed a Full story available on Benzinga.com